122 related articles for article (PubMed ID: 29419620)
1. Cost-effectiveness of the antimicrobial treatment for inpatients infected with Klebsiella pneumoniae carbapenemase: a systematic review protocol.
Dos Santos WM; Matuoka JY; Secoli SR
JBI Database System Rev Implement Rep; 2018 Feb; 16(2):336-344. PubMed ID: 29419620
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence.
Dos Santos WM; Aromataris E; Secoli SR; Matuoka JY
JBI Database System Rev Implement Rep; 2019 Dec; 17(12):2417-2451. PubMed ID: 31821188
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase.
Santos WMD; Secoli SR
Einstein (Sao Paulo); 2019 May; 17(4):eGS4444. PubMed ID: 31116310
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antimicrobial combinations against colistin-resistant carbapenemase (KPC)-producing Klebsiella pneumoniae.
Maraki S; Papadakis IS
J Chemother; 2015; 27(6):348-52. PubMed ID: 25248023
[No Abstract] [Full Text] [Related]
5. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
Li JQ; Tang CQ; Wang H; Ji SZ; Lü KY; Xiao SC; Deng AM; Huang Y; Xia ZF
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1903-6. PubMed ID: 27373357
[TBL] [Abstract][Full Text] [Related]
6. Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.
Gaibani P; Colombo R; Arghittu M; Cariani L; Ambretti S; Bua G; Lombardo D; Landini MP; Torresani E; Sambri V
New Microbiol; 2014 Jan; 37(1):87-90. PubMed ID: 24531175
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.
Mathers AJ; Vegesana K; German-Mesner I; Ainsworth J; Pannone A; Crook DW; Sifri CD; Sheppard A; Stoesser N; Peto T; Walker AS; Eyre DW
J Hosp Infect; 2020 Apr; 104(4):456-468. PubMed ID: 31931046
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Carbapenemase-Producing
Granov D; Dedeić-Ljubović A; Salimović-Bešić I
Microb Drug Resist; 2020 Sep; 26(9):1038-1045. PubMed ID: 32208954
[No Abstract] [Full Text] [Related]
9. Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli Isolates.
Kazemian H; Heidari H; Ghanavati R; Ghafourian S; Yazdani F; Sadeghifard N; Valadbeigi H; Maleki A; Pakzad I
Med Princ Pract; 2019; 28(6):547-551. PubMed ID: 30995662
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia.
Ouertani R; Ben Jomàa-Jemili M; Gharsa H; Limelette A; Guillard T; Brasme L; de Champs C; Chouchani C
Microb Drug Resist; 2018 Mar; 24(2):142-149. PubMed ID: 28737463
[TBL] [Abstract][Full Text] [Related]
11. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain.
Lopez JA; Correa A; Navon-Venezia S; Correa AL; Torres JA; Briceño DF; Montealegre MC; Quinn JP; Carmeli Y; Villegas MV
Clin Microbiol Infect; 2011 Jan; 17(1):52-6. PubMed ID: 20219078
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and Molecular Characterization of Multidrug Resistant Klebsiella pneumoniae Isolated from Different Clinical Sources in Al-Najaf Province-Iraq.
Aljanaby AAJ; Alhasnawi HMRJ
Pak J Biol Sci; 2017; 20(5):217-232. PubMed ID: 29023034
[TBL] [Abstract][Full Text] [Related]
13. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective.
Otter JA; Burgess P; Davies F; Mookerjee S; Singleton J; Gilchrist M; Parsons D; Brannigan ET; Robotham J; Holmes AH
Clin Microbiol Infect; 2017 Mar; 23(3):188-196. PubMed ID: 27746394
[TBL] [Abstract][Full Text] [Related]
14. Carbapenemase producing Klebsiella pneumoniae in Peru: a case report and antimicrobial resistance discussion.
Quispe Pari JF; Ingaruca Rojas JO; Castro Mucha AM; Castro Ortega ML; Ccoicca Hinojosa FJ; Montalvo Otivo R; Prieto Pozo AA; Salvador Sagüez FLD
Medwave; 2018 Apr; 18(2):e7191. PubMed ID: 29652297
[TBL] [Abstract][Full Text] [Related]
15. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: Mortality due to KPC Klebsiella pneumoniae infections.
Ramos-Castañeda JA; Ruano-Ravina A; Barbosa-Lorenzo R; Paillier-Gonzalez JE; Saldaña-Campos JC; Salinas DF; Lemos-Luengas EV
J Infect; 2018 May; 76(5):438-448. PubMed ID: 29477802
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.
Qureshi ZA; Paterson DL; Potoski BA; Kilayko MC; Sandovsky G; Sordillo E; Polsky B; Adams-Haduch JM; Doi Y
Antimicrob Agents Chemother; 2012 Apr; 56(4):2108-13. PubMed ID: 22252816
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from excess mortality associated with Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in liver transplant recipients.
Lübbert C; Rodloff AC; Laudi S; Simon P; Busch T; Mössner J; Bartels M; Kaisers UX
Liver Transpl; 2014 Jun; 20(6):736-8. PubMed ID: 24677425
[No Abstract] [Full Text] [Related]
19. Managing a nosocomial outbreak of carbapenem-resistant Klebsiella pneumoniae: an early Australian hospital experience.
Chang LW; Buising KL; Jeremiah CJ; Cronin K; Poy Lorenzo YS; Howden BP; Kwong J; Cocks J; Blood A; Greenough J; Waters MJ
Intern Med J; 2015 Oct; 45(10):1037-43. PubMed ID: 26178306
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
